Compass Pathways Announces Second Quarter 2025 Financial Results and Business Highlights

Contributed by: Business Wire

Logo

Tags

Mental Health

Research

Biotechnology

Other Health

Alternative Medicine

Health

Pharmaceutical

Other Science

Science

Compass Pathfinder

More Like This

Compass Pathways Announces First Quarter 2025 Financial Results and Business Highlights

Compass Pathways Announces Third Quarter 2024 Financial Results and Business Updates

Compass Pathways Announces Fourth Quarter and Full-Year 2024 Financial Results and Business Highlights

Compass Pathways Announces Dosing Complete for All Participants in Part A of Phase 3 COMP005 Trial of COMP360 Psilocybin for Treatment-Resistant Depression

Compass Pathways Announces Completion of Recruitment for the Phase 3 COMP005 Trial of COMP360 Psilocybin for Treatment-Resistant Depression

Compass Pathways to Announce Second Quarter Financial Results on July 31, 2025

Compass Pathways Successfully Achieves Primary Endpoint in First Phase 3 Trial Evaluating COMP360 Psilocybin for Treatment-Resistant Depression

Compass Pathways Announces Publication of Results from COMP004 Study on COMP360 Psilocybin for Treatment-Resistant Depression